The Effectiveness of Scutellaria baicalensis on Migraine: Implications from Clinical Use and Experimental Proof

Chung-Chih Liao; Ke-Ru Liao; Cheng-Li Lin; Jung-Miao Li

doi:10.1155/2021/8707280

The Effectiveness of Scutellaria baicalensis on Migraine: Implications from Clinical Use and Experimental Proof

Evid Based Complement Alternat Med. 2021 Jan 6:2021:8707280. doi: 10.1155/2021/8707280. eCollection 2021.

Authors

Chung-Chih Liao¹, Ke-Ru Liao², Cheng-Li Lin^{3

4}, Jung-Miao Li^{1

5}

Affiliations

¹ Graduate Institute of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung 40402, Taiwan.
² Department of Neurology, Yuanlin Christian Hospital, Yuanlin 51052, Taiwan.
³ Management Office for Health Data, China Medical University Hospital, Taichung 40447, Taiwan.
⁴ College of Medicine, China Medical University, Taichung 40402, Taiwan.
⁵ Department of Chinese Medicine, Show Chwan Memorial Hospital, Changhua 50008, Taiwan.

Abstract

Background: Scutellaria baicalensis (SB), a traditional Chinese medicine, is commonly used for the treatment of inflammatory and painful conditions. The purpose of the present study was to examine the effects of SB on migraine.

Materials and methods: We examined the clinical applications of SB based on the data obtained from Taiwan's National Health Insurance Research Database and confirmed that it was frequently used in Taiwan for the treatment of headaches. An experimental migraine model was established in rats by an intraperitoneal injection of nitroglycerin (NTG, 10 mg/kg). Pretreatment with SB was given orally 30 min before NTG administration. The rats were subjected to migraine-related behaviour tests that were video-recorded and analysed using EthoVision XT 12.0 software.

Results: The frequency of exploratory and locomotor behaviour was comparatively lower in the NTG group than that in the control group, while the frequency of resting and grooming behaviour increased. These phenomena were ameliorated by pretreatment with 1.0 g/kg SB. The total time spent on the smooth surface was longer in the NTG group than that in the control group, but the time was shortened by pretreatment with 1.0 g/kg SB.

Conclusions: Pretreatment with 1.0 g/kg SB relieved migraine-related behaviours in the experimental NTG-induced migraine model. The outcome therefore demonstrated that pretreatment with 1.0 g/kg SB is beneficial for migraine treatment.